Can the Rideshare Business Model Address All of its Accessibility Concerns?

Key Points:

  1. Gig work transportation companies like Instacart, Lyft and Doordash have faced several ADA lawsuits for lack of application accessibility for the blind and visually impaired.
  2. Increasing accessibility for the blind and visually impaired is an issue facing all mobility providers.
  3. Rideshare companies fill a crucial gap in the market that can’t be filled by cities due to cost.

Commentary:

The emergence of rideshare companies has provided another transportation option for many around the world, but not everyone has had access to this wave off innovation. As we’ve seen over the last year, gig work transportation companies like Instacart, Lyft and Doordash have faced ADA lawsuits for lack of application accessibility for the blind and visually impaired.

Mick Spiers, Vice President Strategy and Marketing at Cubic Transportation Systems, joined MarketScale to tell us if this is reflective of a greater set of accessibility issues that rideshare companies have yet to address. He also went into depth on the role that these companies play in the larger transportation landscape and where he hopes to see mobility move in the future.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More